Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Healthequity (HQY) Long-Term Debt Repayments (2020 - 2026)

Healthequity has reported Long-Term Debt Repayments over the past 8 years, most recently at $25.0 million for Q1 2026.

For Q1 2026, Long-Term Debt Repayments changed 0.0% year-over-year to $25.0 million; the TTM value through Jan 2026 reached $611.9 million, up 8.9%, while the annual FY2026 figure was $100.0 million, 82.2% down from the prior year.
Long-Term Debt Repayments for Q1 2026 was $25.0 million at Healthequity, roughly flat from $25.0 million in the prior quarter.
Over five years, Long-Term Debt Repayments peaked at $536.9 million in Q4 2024 and troughed at $2.2 million in Q2 2022.
A 5-year average of $75.0 million and a median of $25.0 million in 2025 define the central range for Long-Term Debt Repayments.
Biggest five-year swings in Long-Term Debt Repayments: plummeted 99.78% in 2022 and later surged 2386.28% in 2023.
Year by year, Long-Term Debt Repayments stood at $2.2 million in 2022, then surged by 2386.28% to $54.4 million in 2023, then surged by 887.36% to $536.9 million in 2024, then plummeted by 95.34% to $25.0 million in 2025, then changed by 0.0% to $25.0 million in 2026.
Business Quant data shows Long-Term Debt Repayments for HQY at $25.0 million in Q1 2026, $25.0 million in Q4 2025, and $25.0 million in Q1 2025.